The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTI1.L Regulatory News (TI1)

  • There is currently no data for TI1

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value as at 31 January 2021

17 Feb 2021 14:25

RNS Number : 4691P
Trian Investors 1 Limited
17 February 2021
 

17 February 2021

TRIAN INVESTORS 1 LIMITED(the "Company")

 

 

Net Asset Value as at 31 January 2021

 

Trian Investors 1 Limited is pleased to announce its Net Asset Value as at 31 January 2021 was £383 million, or 144.9 pence per Ordinary Share.

 

Company Hedging Activities

 

As the Company has previously noted in its financial reports, Ferguson plc ("Ferguson") receives the vast majority of its revenues and profits in U.S. Dollars and therefore, from the perspective of a Pound Sterling investor, the Company's Ferguson investment may be adversely affected by the appreciation of Pounds Sterling against the U.S. Dollar. In order to mitigate this risk, the Company through Trian Investors 1, L.P. (the "Investment Partnership") entered into a currency hedge in March 2020, in the form of an option (the "March 2020 Option") to purchase £125,000,000 Pounds Sterling for US$165,875,000, to offset a portion of the Company's U.S. Dollar exposure resulting from its investment in Ferguson. The March 2020 Option was originally scheduled to expire in March 2021.

 

In light of the strengthening of Pounds Sterling against the U.S. Dollar over the past several months, the Company through the Investment Partnership recently took advantage of attractive pricing conditions and sold the March 2020 Option for £5,200,000. Simultaneously, the Company through the Investment Partnership entered into a new option (the "February 2021 Option"), which expires in 12 months, to purchase £125,000,000 Pounds Sterling for US$181,250,000, for a premium of £1,743,750. Taken together, these two transactions were designed to allow the Company to recognize cash proceeds of £3,456,250 on a net basis, while still providing it with protection against significant further appreciation of Pounds Sterling against the U.S. Dollar during the next 12 months. However, there is no assurance that the February 2021 Option will be effective at managing the Company's currency exposure. 

 

 

 

For further information, please contact:

 

Numis Securities Limited

(Joint corporate broker) 

+44 (0)20 7260 1000

David Benda

 

Jefferies International Limited

(Joint corporate broker)

+44 (0)20 7029 8000

Stuart Klein

 

Ocorian Administration (Guernsey) Limited(Administrator and Company Secretary)+44 (0)1481 742 742Ian Smith

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVZZGMZDNFGMZM
Date   Source Headline
26th Apr 20234:22 pmRNSNotice of EGM Results
26th Apr 20234:21 pmRNSNotice of AGM Results
26th Apr 20237:30 amRNSSuspension - Trian Investors 1 Limited
17th Apr 20235:03 pmRNSNet Asset Value as at 31 March 2023
6th Apr 20232:55 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
24th Mar 20237:01 amRNSNotice of EGM
24th Mar 20237:00 amRNSNotice of AGM
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
17th Mar 20237:00 amRNSAnnual Report to 31 December 2022
16th Mar 202312:08 pmRNSNAV as at 28 February 2023 and as at 13 March 2023
14th Mar 20232:43 pmRNSTotal Voting Rights
2nd Mar 20237:00 amRNSCompulsory Share Redemption Update
22nd Feb 20232:53 pmRNSNet Asset Value as at 16 February 2023
22nd Feb 20232:37 pmRNSNet Asset Value as at 31 January 2023
17th Feb 20237:00 amRNSCompulsory Share Redemption Update
1st Feb 20237:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSNet Asset Value as at 6 January 2023
19th Jan 20237:00 amRNSIn-specie Distribution & Complusory Redemption
9th Jan 20236:01 pmRNSNet Asset Value as at 31 December 2022
9th Jan 20237:00 amRNSCompulsory Share Redemption Update
14th Dec 20225:26 pmRNSNet Asset Value as at 30 November 2022
11th Nov 20224:34 pmRNSNet Asset Value as at 31 October 2022
26th Oct 20225:16 pmRNSReplacement - Net Asset Value(s)
25th Oct 20224:16 pmRNSNet Asset Value as at 30 September 2022
24th Oct 20228:51 amRNSHolding(s) in Company
15th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSNet Asset Value as at 31 August 2022
6th Sep 202210:42 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompulsory Share Redemption by 30 June 2023
15th Aug 20225:30 pmRNSChanges to Director Roles and Responsibilities
12th Aug 20227:00 amRNSNet Asset Value as at 31 July 2022
8th Aug 20227:00 amRNSResult of EGM
8th Aug 20227:00 amRNSDirector Changes
8th Aug 20227:00 amRNSResult of AGM
11th Jul 20222:01 pmRNSNotice of AGM
11th Jul 20222:00 pmRNSNotice of Requisitioned EGM
11th Jul 20227:00 amRNSNet Asset Value as at 30 June 2022
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20223:56 pmRNSReceipt of Requisition Notice
15th Jun 20227:00 amRNSNet Asset Value as at 31 May 2022
31st May 20228:00 amRNSInvestment in Unilever
6th May 20226:00 pmRNSNet Asset Value as at 30 April 2022
14th Apr 20227:01 amRNSDirector Appointment
14th Apr 20227:00 amRNSAnnual Report to 31 December 2021
13th Apr 20225:53 pmRNSNet Asset Value as at 31 March 2022
29th Mar 202210:11 amRNSNew US$100m Revolving Credit Facility
16th Mar 20224:53 pmRNSNet Asset Value as at 28 February 2022
1st Mar 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.